PE20081173A1 - Marcacion con fluor radioactivo - Google Patents

Marcacion con fluor radioactivo

Info

Publication number
PE20081173A1
PE20081173A1 PE2007001246A PE2007001246A PE20081173A1 PE 20081173 A1 PE20081173 A1 PE 20081173A1 PE 2007001246 A PE2007001246 A PE 2007001246A PE 2007001246 A PE2007001246 A PE 2007001246A PE 20081173 A1 PE20081173 A1 PE 20081173A1
Authority
PE
Peru
Prior art keywords
aryl
alkyl
link
fluor
radioactive
Prior art date
Application number
PE2007001246A
Other languages
English (en)
Inventor
Ananth Srinivasan
Ulrich Klar
Lutz Lehmann
Ulrike Voigtmann
Timo Stellfeld
Aileen Hohne
Linjing Mu
Simon Ametamey
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06076823A external-priority patent/EP1908472A1/en
Priority claimed from EP06076869A external-priority patent/EP1911452A1/en
Priority claimed from EP07090043A external-priority patent/EP1970064A1/en
Priority claimed from EP07090079A external-priority patent/EP1985624A3/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of PE20081173A1 publication Critical patent/PE20081173A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13—Labelling of peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/008—Peptides; Proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0834—Compounds having one or more O-Si linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0896—Compounds with a Si-H linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/12—Organo silicon halides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086—Bombesin; Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nuclear Medicine (AREA)

Abstract

REFERIDA A UN COMPUESTO DE FORMULA (I), DONDE X ES UN GRUPO SALIENTE ADECUADO PARA FLUORACION SELECCIONADO DE H Y OR3; R3 ES H, ALQUILO C1-C10, ALQUENILO C2-C10, ARILO, ENTRE OTROS; R1 Y R2 SON H, ARILO, ENTRE OTROS; B1 ES [CH2]m-D-[CH2]n-A-; n Y m SON UN ENTERO DE 0 A 5; D ES S, O, UN ENLACE O NR4; R4 ES H, ALQUILO C1-C10, ARILO, ENTRE OTROS; E-Z1-Y1 ES EO-C(=O), EC(=O)-O-, EC(=O)-NR5, ENTRE OTROS; R5 ES H, ALQUILO C1-C10, ARILO, ENTRE OTROS; O B2 ES ALQUILO C1-C10, ARILO, HETEROARILO, ENTRE OTROS; Y2 ES C(=O), SO2, S(=O), ENTRE OTROS; m Y n SON UN ENTERO DE 0 A 5; D ES UN ENLACE, S, O O NR9; R9 ES H, ALQUILO C1-C10, ARILO, ENTRE OTROS; E-Z2 ES UN AGENTE DE DIRECCIONAMIENTO RADICAL, DONDE E ES UNA BIOMOLECULA Y Z2 SE SELECCIONA DE UN ENLACE Y UN SEPARADOR TAL COMO UNA SECUENCIA DE AMINOACIDOS NATURAL O ARTIFICIAL O UN GRUPO NO AMINOACIDO. DICHOS COMPUESTOS SON UTILES PARA EL DIAGNOSTICO POR IMAGENES, DE PREFERENCIA PARA LA TOMOGRAFIA DE EMISION DE POSITRONES
PE2007001246A 2006-10-02 2007-09-14 Marcacion con fluor radioactivo PE20081173A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06076823A EP1908472A1 (en) 2006-10-02 2006-10-02 Silicon derivatives for PET imaging
EP06076869A EP1911452A1 (en) 2006-10-11 2006-10-11 Silicon-derivates for PET-Imaging
EP07090043A EP1970064A1 (en) 2007-03-12 2007-03-12 Silicon-derivatives for pet-imaging
EP07090079A EP1985624A3 (en) 2007-04-23 2007-04-23 Single step method of radiofluorination of biologically active compounds or biomolecules

Publications (1)

Publication Number Publication Date
PE20081173A1 true PE20081173A1 (es) 2008-11-06

Family

ID=39030886

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001246A PE20081173A1 (es) 2006-10-02 2007-09-14 Marcacion con fluor radioactivo

Country Status (21)

Country Link
US (1) US20090035215A1 (es)
EP (1) EP2074135A2 (es)
JP (1) JP2010505776A (es)
KR (1) KR20090085599A (es)
AR (1) AR062795A1 (es)
AU (1) AU2007304508A1 (es)
BR (1) BRPI0719956A2 (es)
CA (1) CA2664700A1 (es)
CO (1) CO6180444A2 (es)
CR (1) CR10703A (es)
IL (1) IL197817A0 (es)
MA (1) MA30824B1 (es)
MX (1) MX2009003617A (es)
NO (1) NO20091735L (es)
PA (1) PA8747601A1 (es)
PE (1) PE20081173A1 (es)
SV (1) SV2009003205A (es)
TN (1) TN2009000100A1 (es)
TW (1) TW200820988A (es)
UY (1) UY30596A1 (es)
WO (1) WO2008040441A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2627486T3 (es) 2010-01-25 2017-07-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Biomoléculas sililadas
JP5717138B2 (ja) * 2011-05-23 2015-05-13 独立行政法人産業技術総合研究所 タンパク質固定化表面修飾材料
WO2014196540A1 (ja) * 2013-06-06 2014-12-11 日産化学工業株式会社 アルコキシシラン化合物、液晶配向剤、液晶配向膜及び液晶表示素子
US10800797B2 (en) 2015-05-26 2020-10-13 California Institute Of Technology Heteroaromatic silicon-fluoride-acceptors useful for 18F labeling of molecules and biomolecules, and methods of preparing same
WO2019055825A1 (en) 2017-09-15 2019-03-21 The Regents Of The University Of California INHIBITION OF AMINOACYLASE 3 (AA3) IN THE TREATMENT OF CANCER
WO2021226076A1 (en) * 2020-05-04 2021-11-11 The Research Foundation For The State University Of New York Positron imaging tomography imaging agent composition and method for detection of bacterial infection
EP4218831A4 (en) * 2020-09-28 2024-03-06 National Institutes for Quantum Science and Technology METHOD FOR PRODUCING A RADIOACTIVELY LABELED SUBSTANCE, DEVICE FOR PRODUCING A RADIOACTIVELY LABELED SUBSTANCE AND METHOD FOR THE VAPORIZATION AND CONCENTRATION OF RADIOACTIVE METAL NUCLIDE

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084555A (en) * 1989-08-21 1992-01-28 The Administrators Of The Tulane Educational Fund An octapeptide bombesin analog
US5732578A (en) * 1995-02-24 1998-03-31 Hyundai Metal Co., Ltd. Device for maintaining the horizontality of a door lock lever
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
US6639076B1 (en) * 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
JP2003502314A (ja) * 1999-06-14 2003-01-21 イーライ・リリー・アンド・カンパニー 化合物
AU2002228725A1 (en) * 2000-11-30 2002-06-11 Advanced Research And Technology Institute, Inc. Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
GB0206750D0 (en) * 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
US7342095B2 (en) * 2003-02-20 2008-03-11 University Of South Florida Peptidomimetic inhibitors of STAT activity and uses thereof
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
EP1723161A4 (en) * 2004-02-13 2010-04-28 Univ British Columbia RADIOACTIVELY MARKED COMPOUNDS AND COMPOSITIONS, PRECURSORS AND METHOD FOR THE PRODUCTION THEREOF
US20080029548A1 (en) * 2006-05-05 2008-02-07 Ann De Wree Fabric treatment dispensing package

Also Published As

Publication number Publication date
EP2074135A2 (en) 2009-07-01
CR10703A (es) 2009-06-25
KR20090085599A (ko) 2009-08-07
TW200820988A (en) 2008-05-16
IL197817A0 (en) 2009-12-24
JP2010505776A (ja) 2010-02-25
TN2009000100A1 (en) 2010-08-19
UY30596A1 (es) 2008-05-02
CA2664700A1 (en) 2008-04-10
SV2009003205A (es) 2009-10-19
MA30824B1 (fr) 2009-10-01
CO6180444A2 (es) 2010-07-19
WO2008040441A2 (en) 2008-04-10
AR062795A1 (es) 2008-12-03
NO20091735L (no) 2009-06-30
WO2008040441A3 (en) 2009-01-08
US20090035215A1 (en) 2009-02-05
AU2007304508A1 (en) 2008-04-10
MX2009003617A (es) 2009-04-22
PA8747601A1 (es) 2009-08-26
BRPI0719956A2 (pt) 2014-04-29
AU2007304508A8 (en) 2009-05-14

Similar Documents

Publication Publication Date Title
PE20081173A1 (es) Marcacion con fluor radioactivo
PE20061159A1 (es) Derivados de acido hidroxibifenilcarboxilico y procedimientos para prepararlos
PE20091956A1 (es) Derivados de acido l-glutamico y l-glutamina marcados con [f-18]
PE20091723A1 (es) Derivados de acido l-glutamico marcado con [18 f] y l-glutamina marcada con [18f]
PE20130684A1 (es) Derivados de carbamato de hexafluoroisopropilo y su preparacion
GEP20115359B (en) Fused cyclic compounds
PE20141378A1 (es) Moduladores de receptores de glucocorticoides de pirimidina ciclohexilo
RU2008139905A (ru) Фармацевтическая композиция для наружного применения
RU2009105640A (ru) Агенты для визуализации
BRPI0516911A (pt) método para a preparação de um composto e composto de anilina
MXPA05006907A (es) Compuestos diazoicos cationicos, composiciones que los contienen como colorante directo, procedimiento de coloracion de fibras queratinicas y dispositivo.
EA200601388A1 (ru) Соединения, модулирующие рецептор gpr40, фармацевтическая композиция, способ лечения заболеваний, чувствительных к модулированию рецептора gpr40 (варианты), способ модулирования функции gpr40 (варианты) и способ модулирования циркулирующей концентрации инсулина
PE20070009A1 (es) Tigeciclina y metodos para su preparacion
PE20150041A1 (es) Derivados de aminoacidos funcionalizados en la terminal n capaces de formar microesferas encapsuladoras de farmaco
PE20050142A1 (es) 2-hidroxi-3-diaminoalcanos de benzamida
RU2008130887A (ru) Водорастворимое соединение бензоазепина и содержащая его фармацевтическая композиция
UY32336A (es) Nuevos compuestos de acido 2-({ [(1Z)-1-2(2-amino-1,3-tiazol-4-il)-2-{ [(3S)-1-({ [5-hidroxi-4-oxo-1,4-dihidropiridin-2-il)-5-oxo-4-propil-4, 5 - dihidro - 1H - 1, 2, 4 - trialzol - 1 - il]sulfonil} carbamoil) -2 - oxazetidin -3 -il] amino} - 2 - oxoetiliden] amino} oxi) - 2 - metilpropanoico, composiciones farmacéuticas conteniendolos y aplicaciones.
PE20091401A1 (es) Procedimientos para preparar eteres aromaticos
RU2015122032A (ru) Оксазолидинонсодержащие соединения, композиции и способы их использования
BR112012024403A2 (pt) processo de preparo de derivados de amino-benzofurano
MX341173B (es) Proceso de fluorinado de derivados de anilida y derivados de fluorinado de benzotiazole en la forma de agentes de generacion de imagen in vivo.
JP2009500441A5 (es)
PE20080668A1 (es) Compuestos heterociclicos como inhibidores de la cinasa-2 de proteina activada por cinasa de proteina activada por mitogeno
RU2001118831A (ru) Макролиды, обладающие противовоспалительной активностью
RU2007148018A (ru) Способ получения замещенных тетрафторбензиланилиновых соединений и их фармацевтически приемлемых солей

Legal Events

Date Code Title Description
FD Application declared void or lapsed